February 12, 2018 / 11:44 AM / in 9 months

BRIEF-Sanofi Pasteur strucks licence agreement with SK Chemicals

Feb 12 (Reuters) - Sanofi:

* SK Chemicals announces license agreement with Sanofi Pasteur in cell culture technology for potential use in Sanofi’s strategic broadly protective influenza vaccine development program

* agreement between SK Chemicals and Sanofi Pasteur is eligible for payment of up to $155 million when achieving all milestones Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below